{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T18:08:35Z","timestamp":1776449315767,"version":"3.51.2"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2011,7,3]],"date-time":"2011-07-03T00:00:00Z","timestamp":1309651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s11010-011-0929-8","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T06:48:50Z","timestamp":1309762130000},"page":"141-151","source":"Crossref","is-referenced-by-count":36,"title":["Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells"],"prefix":"10.1007","volume":"358","author":[{"given":"Peeyush N.","family":"Goel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. P.","family":"Gude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,3]]},"reference":[{"key":"929_CR1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893\u20132917","journal-title":"Int J Cancer"},{"key":"929_CR2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277\u2013300","journal-title":"CA Cancer J Clin"},{"key":"929_CR3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrc2622","volume":"9","author":"DX Nguyen","year":"2009","unstructured":"Nguyen DX, Bos PD, Massague J (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9:274\u2013284","journal-title":"Nat Rev Cancer"},{"key":"929_CR4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1634\/theoncologist.2009-0078","volume":"14","author":"V Guarneri","year":"2009","unstructured":"Guarneri V, Conte P (2009) Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy. Oncologist 14:645\u2013656","journal-title":"Oncologist"},{"key":"929_CR5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/j.1552-4604.1985.tb02796.x","volume":"25","author":"HR Dettelbach","year":"1985","unstructured":"Dettelbach HR, Aviado DM (1985) Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication. J Clin Pharmacol 25:8\u201326","journal-title":"J Clin Pharmacol"},{"key":"929_CR6","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2165\/00003495-200464150-00004","volume":"64","author":"D Jacoby","year":"2004","unstructured":"Jacoby D, Mohler ER 3rd (2004) Drug treatment of intermittent claudication. Drugs 64:1657\u20131670","journal-title":"Drugs"},{"key":"929_CR7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0049-3848(74)90167-4","volume":"5","author":"H Gastpar","year":"1974","unstructured":"Gastpar H (1974) The inhibition of cancer cell stickness by the methylxanthine derivative pentoxifylline (BL 191). Thromb Res 5:277\u2013289","journal-title":"Thromb Res"},{"key":"929_CR8","first-page":"103","volume":"9","author":"M Zhang","year":"2004","unstructured":"Zhang M, Xu YJ, Mengi SA, Arneja AS, Dhalla NS (2004) Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases. Exp Clin Cardiol 9:103\u2013111","journal-title":"Exp Clin Cardiol"},{"key":"929_CR9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0192-0561(97)85556-7","volume":"18","author":"CL D\u2019Hellencourt","year":"1996","unstructured":"D\u2019Hellencourt CL, Diaw L, Cornillet P, Guenounou M (1996) Differential regulation of TNF alpha, IL-1 beta, IL-6, IL-8, TNF beta, and IL-10 by pentoxifylline. Int J Immunopharmacol 18:739\u2013748","journal-title":"Int J Immunopharmacol"},{"key":"929_CR10","doi-asserted-by":"crossref","first-page":"H832","DOI":"10.1152\/ajpheart.00178.2005","volume":"289","author":"M Zhang","year":"2005","unstructured":"Zhang M, Xu YJ, Saini HK, Turan B, Liu PP, Dhalla NS (2005) Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in ischemic-reperfused heart. Am J Physiol Heart Circ Physiol 289:H832\u2013H839","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"929_CR11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/1097-0215(20001020)90:5<256::AID-IJC2>3.0.CO;2-R","volume":"90","author":"DR Collingridge","year":"2000","unstructured":"Collingridge DR, Rockwell S (2000) Pentoxifylline improves the oxygenation and radiation response of BA1112 rat rhabdomyosarcomas and EMT6 mouse mammary carcinomas. Int J Cancer 90:256\u2013264","journal-title":"Int J Cancer"},{"key":"929_CR12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0300-483X(03)00294-4","volume":"193","author":"L Bohm","year":"2003","unstructured":"Bohm L, Roos WP, Serafin AM (2003) Inhibition of DNA repair by pentoxifylline and related methylxanthine derivatives. Toxicology 193:153\u2013160","journal-title":"Toxicology"},{"key":"929_CR13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0962-8924(02)02294-8","volume":"12","author":"PJ Stork","year":"2002","unstructured":"Stork PJ, Schmitt JM (2002) Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 12:258\u2013266","journal-title":"Trends Cell Biol"},{"key":"929_CR14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1097-2765(03)00529-X","volume":"13","author":"A Shmueli","year":"2004","unstructured":"Shmueli A, Oren M (2004) Regulation of p53 by Mdm2: fate is in the numbers. Mol Cell 13:4\u20135","journal-title":"Mol Cell"},{"key":"929_CR15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/cm.10128","volume":"55","author":"HL Glenn","year":"2003","unstructured":"Glenn HL, Jacobson BS (2003) Cyclooxygenase and cAMP-dependent protein kinase reorganize the actin cytoskeleton for motility in HeLa cells. Cell Motil Cytoskeleton 55:265\u2013277","journal-title":"Cell Motil Cytoskeleton"},{"key":"929_CR16","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.ejca.2008.04.009","volume":"44","author":"P Dua","year":"2008","unstructured":"Dua P, Gude RP (2008) Pentoxifylline impedes migration in B16F10 melanoma by modulating Rho GTPase activity and actin organisation. Eur J Cancer 44:1587\u20131595","journal-title":"Eur J Cancer"},{"key":"929_CR17","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.4161\/cbt.6.11.4833","volume":"6","author":"A Ratheesh","year":"2007","unstructured":"Ratheesh A, Ingle A, Gude RP (2007) Pentoxifylline modulates cell surface integrin expression and integrin mediated adhesion of B16F10 cells to extracellular matrix components. Cancer Biol Ther 6:1743\u20131752","journal-title":"Cancer Biol Ther"},{"key":"929_CR18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00280-005-0155-8","volume":"58","author":"P Dua","year":"2006","unstructured":"Dua P, Gude RP (2006) Antiproliferative and antiproteolytic activity of pentoxifylline in cultures of B16F10 melanoma cells. Cancer Chemother Pharmacol 58:195\u2013202","journal-title":"Cancer Chemother Pharmacol"},{"key":"929_CR19","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1074\/jbc.M110709200","volume":"277","author":"GA Di Lullo","year":"2002","unstructured":"Di Lullo GA, Sweeney SM, Korkko J, Ala-Kokko L, San Antonio JD (2002) Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J Biol Chem 277:4223\u20134231","journal-title":"J Biol Chem"},{"key":"929_CR20","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NA Franken","year":"2006","unstructured":"Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1:2315\u20132319","journal-title":"Nat Protoc"},{"key":"929_CR21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6750-5-12","volume":"5","author":"D Ribble","year":"2005","unstructured":"Ribble D, Goldstein NB, Norris DA, Shellman YG (2005) A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol 5:12","journal-title":"BMC Biotechnol"},{"key":"929_CR22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/sj.bjc.6605101","volume":"101","author":"CS Pichot","year":"2009","unstructured":"Pichot CS, Hartig SM, Xia L, Arvanitis C, Monisvais D, Lee FY, Frost JA, Corey SJ (2009) Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells. Br J Cancer 101:38\u201347","journal-title":"Br J Cancer"},{"key":"929_CR23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jnutbio.2007.05.008","volume":"19","author":"HS Lee","year":"2008","unstructured":"Lee HS, Seo EY, Kang NE, Kim WK (2008) [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J Nutr Biochem 19:313\u2013319","journal-title":"J Nutr Biochem"},{"key":"929_CR24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1476-4598-8-81","volume":"8","author":"S Wang","year":"2009","unstructured":"Wang S, Liu Q, Zhang Y, Liu K, Yu P, Liu K, Luan J, Duan H, Lu Z, Wang F, Wu E, Yagasaki K, Zhang G (2009) Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Mol Cancer 8:81","journal-title":"Mol Cancer"},{"key":"929_CR25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57\u201370","journal-title":"Cell"},{"key":"929_CR26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.bcp.2004.05.026","volume":"68","author":"L Hirsh","year":"2004","unstructured":"Hirsh L, Dantes A, Suh BS, Yoshida Y, Hosokawa K, Tajima K, Kotsuji F, Merimsky O, Amsterdam A (2004) Phosphodiesterase inhibitors as anti-cancer drugs. Biochem Pharmacol 68:981\u2013988","journal-title":"Biochem Pharmacol"},{"key":"929_CR27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrc1670","volume":"5","author":"B Weigelt","year":"2005","unstructured":"Weigelt B, Peterse JL, van\u2018t Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5:591\u2013602","journal-title":"Nat Rev Cancer"},{"key":"929_CR28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127:679\u2013695","journal-title":"Cell"},{"key":"929_CR29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-6296(02)00126-1","volume":"22","author":"JA DiMasi","year":"2003","unstructured":"DiMasi JA, Hansen RW, Grabowski HG (2003) The price of innovation: new estimates of drug development costs. J Health Econ 22:151\u2013185","journal-title":"J Health Econ"},{"key":"929_CR30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4161\/cbt.80","volume":"1","author":"TC Chen","year":"2002","unstructured":"Chen TC, Wadsten P, Su S, Rawlinson N, Hofman FM, Hill CK, Schonthal AH (2002) The type IV phosphodiesterase inhibitor rolipram induces expression of the cell cycle inhibitors p21(Cip1) and p27(Kip1), resulting in growth inhibition, increased differentiation, and subsequent apoptosis of malignant A-172 glioma cells. Cancer Biol Ther 1:268\u2013276","journal-title":"Cancer Biol Ther"},{"key":"929_CR31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ntt.2003.07.013","volume":"26","author":"HC Gallagher","year":"2004","unstructured":"Gallagher HC, Bacon CL, Odumeru OA, Gallagher KF, Fitzpatrick T, Regan CM (2004) Valproate activates phosphodiesterase-mediated cAMP degradation: relevance to C6 glioma G1 phase progression. Neurotoxicol Teratol 26:73\u201381","journal-title":"Neurotoxicol Teratol"},{"key":"929_CR32","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1124\/mol.64.4.811","volume":"64","author":"SL Lin","year":"2003","unstructured":"Lin SL, Chen RH, Chen YM, Chiang WC, Tsai TJ, Hsieh BS (2003) Pentoxifylline inhibits platelet-derived growth factor-stimulated cyclin D1 expression in mesangial cells by blocking Akt membrane translocation. Mol Pharmacol 64:811\u2013822","journal-title":"Mol Pharmacol"},{"key":"929_CR33","doi-asserted-by":"crossref","first-page":"e10786","DOI":"10.1371\/journal.pone.0010786","volume":"5","author":"ML Polo","year":"2010","unstructured":"Polo ML, Arnoni MV, Riggio M, Wargon V, Lanari C, Novaro V (2010) Responsiveness to PI3K and MEK inhibitors in breast cancer. Use of a 3D culture system to study pathways related to hormone independence in mice. PLoS One 5:e10786","journal-title":"PLoS One"},{"key":"929_CR34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1007429904664","volume":"14","author":"C Renvoize","year":"1998","unstructured":"Renvoize C, Biola A, Pallardy M, Breard J (1998) Apoptosis: identification of dying cells. Cell Biol Toxicol 14:111\u2013120","journal-title":"Cell Biol Toxicol"},{"key":"929_CR35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161\u2013174","journal-title":"Nat Rev Cancer"},{"key":"929_CR36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52\u201367","journal-title":"Cell"},{"key":"929_CR37","first-page":"885","volume":"16","author":"HG Farina","year":"2006","unstructured":"Farina HG, Pomies M, Alonso DF, Gomez DE (2006) Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol Rep 16:885\u2013891","journal-title":"Oncol Rep"},{"key":"929_CR38","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1054\/bjoc.2001.1810","volume":"84","author":"A Scorilas","year":"2001","unstructured":"Scorilas A, Karameris A, Arnogiannaki N, Ardavanis A, Bassilopoulos P, Trangas T, Talieri M (2001) Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. Br J Cancer 84:1488\u20131496","journal-title":"Br J Cancer"},{"key":"929_CR39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.cmr.0000215033.92693.73","volume":"16","author":"YG Shellman","year":"2006","unstructured":"Shellman YG, Makela M, Norris DA (2006) Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines. Melanoma Res 16:207\u2013211","journal-title":"Melanoma Res"},{"key":"929_CR40","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/0006-291X(90)91190-4","volume":"171","author":"Y Okada","year":"1990","unstructured":"Okada Y, Tsuchiya H, Shimizu H, Tomita K, Nakanishi I, Sato H, Seiki M, Yamashita K, Hayakawa T (1990) Induction and stimulation of 92-kDa gelatinase\/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha. Biochem Biophys Res Commun 171:610\u2013617","journal-title":"Biochem Biophys Res Commun"},{"key":"929_CR41","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1182\/blood.V83.12.3638.3638","volume":"83","author":"C Ries","year":"1994","unstructured":"Ries C, Kolb H, Petrides PE (1994) Regulation of 92\u00a0kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion. Blood 83:3638\u20133646","journal-title":"Blood"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-011-0929-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-011-0929-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-011-0929-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T02:40:54Z","timestamp":1592707254000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-011-0929-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,3]]},"references-count":41,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["929"],"URL":"https:\/\/doi.org\/10.1007\/s11010-011-0929-8","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,3]]}}}